# Sonnerie VC

Investor in Lewes, Delaware

## About Sonnerie VC

Sonnerie VC Fund I is a pre-seed fund in New York, backing U.S. healthcare and technology startups in regulated markets. Operator-led, it draws on the GPs’ on-thesis $1.3B strategic exit in this space. Born from the Columbia alumni network, and focused on impactful innovation.

At Sonnerie VC, our mission is to amplify bold ideas. We back visionary founders building transformative solutions with lasting impact, empowering them with capital, operational insight, and a global network to scale their companies from signal to success.

What is Sonnerie? An operator-led, pre-seed and seed venture firm. The first institutional check into university healthcare spinouts.

What stage? Pre-seed and seed, the first institutional check at formation, with conviction through the seed round.

What do you back? Therapeutics, medical devices, life sciences and diagnostics, and regulated health technology.

Where? Across the United States, from New York, alongside university tech transfer offices and founders.

We partner before there’s a company to partner with, alongside the founders and the tech transfer offices that hold the science.

## People

- **Tomasz Felpel**, Managing Partner

## Key Facts

- **Location:** Lewes, Delaware
- **Investor Type:** Venture Capital
- **Founded:** 2025

## Investment Industries

- Biotech
- Medical/Healthcare

## How to Contact

Direct messaging, this investor's website, and their LinkedIn and X profiles are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/sonnerie-vc
- More investors: [Biotech Investors in Delaware](https://askforfunding.com/site/angel-investors/delaware/biotech)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.